Glutathione Reductase-Sensitive Polymeric Micelles for Controlled Drug Delivery on Arthritic Diseases

last updated: 2022-01-03
ProjectCells4_IDs :: publications list
TitleGlutathione Reductase-Sensitive Polymeric Micelles for Controlled Drug Delivery on Arthritic Diseases
Publication TypePapers in Scientific Journals
Year of Publication2021
AuthorsLima, Ana C., Reis R. L., Ferreira H., and Neves N. M.
Abstract

Inflammation plays an essential role in arthritis development and progression. Despite the advances in the
pharmaceutical field, current treatments still present low efficacy and severe side effects. Considering the high activity of the glutathione reductase (GR) enzyme in inflamed joints, a distinctive drug delivery system sensitive to the GR enzyme was designed for efficient drug delivery on arthritic diseases. A linear amphiphilic
polymer composed of methoxypolyethylene glycol amine-glutathione- palmitic acid (mPEG-GSHn-PA) was synthesized and the intermolecular oxidation of the thiol groups from GSHs retain the drug inside the resulting micelles. Stable polymeric micelles of 100 nm of size presented a loading capacity of dexamethasone (Dex) up to 65%. Although in physiological conditions the Dex release presented slow and sustained kinetics, in the presence of the GR enzyme, there was a burst release (stimuli-responsive properties). Biological assays demonstrated their cytocompatibility in contact with human articular chondrocytes, macrophages, and endothelial cells as well as their hemocompatibility. Importantly, in an in vitro model of inflammation, the polymeric micelles promoted a controlled drug release in the presence of GR, exhibiting a higher efficacy than the free Dex while reducing the negative effects of the drug into normal cells. In conclusion, this formulation is a promising approach to treat arthritic diseases and other inflammatory conditions.

JournalACS Biomaterials Science & Engineering
Volume7
Edition7
Pagination3229-3241
Date Published2021-07-12
PublisherAmerican Chemical Society
ISSN2373-9878
DOI10.1021/acsbiomaterials.1c00412
URLhttps://pubs.acs.org/doi/pdf/10.1021/acsbiomaterials.1c00412
KeywordsArthritic diseases, controlled release, enzymatic-sensitive micelles, inflammation targeting, polymeric micelles
RightsopenAccess
Peer reviewedyes
Statuspublished

Back to top